Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Dyslipidemia

  Free Subscription


Articles published in J Am Coll Cardiol

Retrieve available abstracts of 45 articles:
HTML format



Single Articles


    October 2021
  1. TALASAZ AH, Sadeghipour P, Aghakouchakzadeh M, Dreyfus I, et al
    Investigating Lipid-Modulating Agents for Prevention or Treatment of COVID-19: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2021;78:1635-1654.
    PubMed     Abstract available


    June 2021
  2. SABATINE MS, Braunwald E
    Thrombolysis In Myocardial Infarction (TIMI) Study Group: JACC Focus Seminar 2/8.
    J Am Coll Cardiol. 2021;77:2822-2845.
    PubMed     Abstract available


    March 2021
  3. TSIMIKAS S, Moriarty PM, Stroes ES
    Emerging RNA Therapeutics to Lower Blood Levels of Lp(a): JACC Focus Seminar 2/4.
    J Am Coll Cardiol. 2021;77:1576-1589.
    PubMed     Abstract available


  4. NURMOHAMED NS, Navar AM, Kastelein JJP
    New and Emerging Therapies for Reduction of LDL-Cholesterol and Apolipoprotein B: JACC Focus Seminar 1/4.
    J Am Coll Cardiol. 2021;77:1564-1575.
    PubMed     Abstract available


  5. JOHANNESEN CDL, Mortensen MB, Langsted A, Nordestgaard BG, et al
    Apolipoprotein B and Non-HDL Cholesterol Better Reflect Residual Risk Than LDL Cholesterol in Statin-Treated Patients.
    J Am Coll Cardiol. 2021;77:1439-1450.
    PubMed     Abstract available


  6. WRIGHT RS, Ray KK, Raal FJ, Kallend DG, et al
    Pooled Patient-Level Analysis of Inclisiran Trials in Patients With Familial Hypercholesterolemia or Atherosclerosis.
    J Am Coll Cardiol. 2021;77:1182-1193.
    PubMed     Abstract available


    February 2021
  7. PERAKAKIS N, Farr OM, Mantzoros CS
    Leptin in Leanness and Obesity: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2021;77:745-760.
    PubMed     Abstract available


  8. CICERO AFG, Fogacci F, Zambon A
    Red Yeast Rice for Hypercholesterolemia: JACC Focus Seminar.
    J Am Coll Cardiol. 2021;77:620-628.
    PubMed     Abstract available


    January 2021
  9. PIETRI P, Stefanadis C
    Cardiovascular Aging and Longevity: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2021;77:189-204.
    PubMed     Abstract available


    December 2020
  10. GHOSHHAJRA BB, Foldyna B, Gaudet D, Khoury E, et al
    Coronary Atheroma Regression From Infusions of Autologous Selectively Delipidated Prebeta-HDL-Enriched Plasma in Homozygous Familial Hypercholesterolemia.
    J Am Coll Cardiol. 2020;76:3062-3064.
    PubMed    


  11. CASTANER O, Pinto X, Subirana I, Amor AJ, et al
    Remnant Cholesterol, Not LDL Cholesterol, Is Associated With Incident Cardiovascular Disease.
    J Am Coll Cardiol. 2020;76:2712-2724.
    PubMed     Abstract available


  12. KRISHNASWAMI A, Beavers C, Dorsch MP, Dodson JA, et al
    Gerotechnology for Older Adults With Cardiovascular Diseases: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2020;76:2650-2670.
    PubMed     Abstract available


    November 2020
  13. BHATT DL, Budoff MJ, Mason RP
    A Revolution in Omega-3 Fatty Acid Research.
    J Am Coll Cardiol. 2020;76:2098-2101.
    PubMed    


    October 2020
  14. MECHANICK JI, Rosenson RS, Pinney SP, Mancini DM, et al
    Coronavirus and Cardiometabolic Syndrome: JACC Focus Seminar.
    J Am Coll Cardiol. 2020;76:2024-2035.
    PubMed     Abstract available


    September 2020
  15. BOCCARA F, Rosenson RS
    Reply: Role of Ezetimibe in the Current Era in Treating Dyslipidemia in HIV-Infected Patients.
    J Am Coll Cardiol. 2020;76:1503-1504.
    PubMed    


  16. SINGH A, Mittal S, Kazimuddin M
    Role of Ezetimibe in the Current Era in Treating Dyslipidemia in HIV-Infected Patients.
    J Am Coll Cardiol. 2020;76:1503.
    PubMed    


  17. ROSENSON RS, Colantonio LD, Goonewardena SN
    Optimizing Cholesterol Management Improves the Benefits of Percutaneous Coronary Intervention.
    J Am Coll Cardiol. 2020;76:1451-1454.
    PubMed    


    July 2020
  18. THOMPSON GR
    PCSK9 Inhibitors for Homozygous Familial Hypercholesterolemia: Useful But Seldom Sufficient.
    J Am Coll Cardiol. 2020;76:143-145.
    PubMed    


  19. BLOM DJ, Harada-Shiba M, Rubba P, Gaudet D, et al
    Efficacy and Safety of Alirocumab in Adults With Homozygous Familial Hypercholesterolemia: The ODYSSEY HoFH Trial.
    J Am Coll Cardiol. 2020;76:131-142.
    PubMed     Abstract available


    June 2020
  20. TOTH PP
    Familial Hypercholesterolemia and Lipoprotein(a): Unraveling the Knot That Binds Them.
    J Am Coll Cardiol. 2020;75:2694-2697.
    PubMed    


  21. TRINDER M, DeCastro ML, Azizi H, Cermakova L, et al
    Ascertainment Bias in the Association Between Elevated Lipoprotein(a) and Familial Hypercholesterolemia.
    J Am Coll Cardiol. 2020;75:2682-2693.
    PubMed     Abstract available


    May 2020
  22. KASTELEIN JJP, Reeskamp LF, Hovingh GK
    Familial Hypercholesterolemia: The Most Common Monogenic Disorder in Humans.
    J Am Coll Cardiol. 2020;75:2567-2569.
    PubMed    


  23. BEHESHTI SO, Madsen CM, Varbo A, Nordestgaard BG, et al
    Worldwide Prevalence of Familial Hypercholesterolemia: Meta-Analyses of 11 Million Subjects.
    J Am Coll Cardiol. 2020;75:2553-2566.
    PubMed     Abstract available


  24. BOCCARA F, Kumar PN, Caramelli B, Calmy A, et al
    Evolocumab in HIV-Infected Patients With Dyslipidemia: Primary Results of the Randomized, Double-Blind BEIJERINCK Study.
    J Am Coll Cardiol. 2020;75:2570-2584.
    PubMed     Abstract available


  25. BHATT DL, Briggs AH, Reed SD, Annemans L, et al
    Cost-Effectiveness of Alirocumab in Patients With Acute Coronary Syndromes: The ODYSSEY OUTCOMES Trial.
    J Am Coll Cardiol. 2020;75:2297-2308.
    PubMed     Abstract available


  26. DURAN EK, Aday AW, Cook NR, Buring JE, et al
    Triglyceride-Rich Lipoprotein Cholesterol, Small Dense LDL Cholesterol, and Incident Cardiovascular Disease.
    J Am Coll Cardiol. 2020;75:2122-2135.
    PubMed     Abstract available


    April 2020
  27. DIENER HC, Hankey GJ
    Primary and Secondary Prevention of Ischemic Stroke and Cerebral Hemorrhage: JACC Focus Seminar.
    J Am Coll Cardiol. 2020;75:1804-1818.
    PubMed     Abstract available


  28. LOPEZ-MELGAR B, Fernandez-Friera L, Oliva B, Garcia-Ruiz JM, et al
    Short-Term Progression of Multiterritorial Subclinical Atherosclerosis.
    J Am Coll Cardiol. 2020;75:1617-1627.
    PubMed     Abstract available


    February 2020
  29. DUELL PB, Fazio S
    Aggressive Treatment for Severe Forms of Familial Hypercholesterolemia.
    J Am Coll Cardiol. 2020;75:575-577.
    PubMed    


  30. SANTOS RD, Stein EA, Hovingh GK, Blom DJ, et al
    Long-Term Evolocumab in Patients With Familial Hypercholesterolemia.
    J Am Coll Cardiol. 2020;75:565-574.
    PubMed     Abstract available


    January 2020
  31. WEINGARTNER O, Sijbrands EJG, Lutjohann D
    Optimizing Clinical Cardiovascular Outcomes by a Personalized Approach to Add Ezetimibe to a Statin.
    J Am Coll Cardiol. 2020;75:128.
    PubMed    


    June 2019
  32. NTALLA I, Kanoni S, Zeng L, Giannakopoulou O, et al
    Genetic Risk Score for Coronary Disease Identifies Predispositions to Cardiovascular and Noncardiovascular Diseases.
    J Am Coll Cardiol. 2019;73:2932-2942.
    PubMed     Abstract available


  33. GRANGER CB, Nelson AJ, Pagidipati NJ
    Risk of Total Events With Icosapent Ethyl: Can We Reduce It?
    J Am Coll Cardiol. 2019;73:2803-2805.
    PubMed    


  34. BHATT DL, Steg PG, Miller M, Brinton EA, et al
    Effects of Icosapent Ethyl on Total Ischemic Events: From REDUCE-IT.
    J Am Coll Cardiol. 2019;73:2791-2802.
    PubMed     Abstract available


    May 2019
  35. HOVINGH GK, Reeskamp LF, Ray KK
    Hypercholesterolemia Among Premature Infarcts: Time to Start the Clock of Familial Hypercholesterolemia Assessment.
    J Am Coll Cardiol. 2019;73:2451-2453.
    PubMed    


  36. SINGH A, Gupta A, Collins BL, Qamar A, et al
    Familial Hypercholesterolemia Among Young Adults With Myocardial Infarction.
    J Am Coll Cardiol. 2019;73:2439-2450.
    PubMed     Abstract available


  37. ZHENG KH, Tsimikas S, Pawade T, Kroon J, et al
    Lipoprotein(a) and Oxidized Phospholipids Promote Valve Calcification in Patients With Aortic Stenosis.
    J Am Coll Cardiol. 2019;73:2150-2162.
    PubMed     Abstract available


  38. NATARAJAN P, Collier TS, Jin Z, Lyass A, et al
    Association of an HDL Apolipoproteomic Score With Coronary Atherosclerosis and Cardiovascular Death.
    J Am Coll Cardiol. 2019;73:2135-2145.
    PubMed     Abstract available


    April 2019
  39. LARA KM, Levitan EB, Gutierrez OM, Shikany JM, et al
    Dietary Patterns and Incident Heart Failure in U.S. Adults Without Known Coronary Disease.
    J Am Coll Cardiol. 2019;73:2036-2045.
    PubMed     Abstract available


    March 2019
  40. TSIMIKAS S
    In Search of Patients With Elevated Lp(a): Seek and Ye Shall Find.
    J Am Coll Cardiol. 2019;73:1040-1042.
    PubMed    


  41. ELLIS KL, Perez de Isla L, Alonso R, Fuentes F, et al
    Value of Measuring Lipoprotein(a) During Cascade Testing for Familial Hypercholesterolemia.
    J Am Coll Cardiol. 2019;73:1029-1039.
    PubMed     Abstract available


  42. JUKEMA JW, Szarek M, Zijlstra LE, de Silva HA, et al
    Patients with Recent Acute Coronary Syndrome and Polyvascular Disease Derive Large Absolute Benefit from Alirocumab: ODYSSEY OUTCOMES Trial.
    J Am Coll Cardiol. 2019 Mar 12. pii: S0735-1097(19)33921.
    PubMed     Abstract available


  43. ARNETT DK, Blumenthal RS, Albert MA, Michos ED, et al
    2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary.
    J Am Coll Cardiol. 2019 Mar 7. pii: S0735-1097(19)33876.
    PubMed    


  44. ARNETT DK, Blumenthal RS, Albert MA, Michos ED, et al
    2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease.
    J Am Coll Cardiol. 2019 Mar 7. pii: S0735-1097(19)33877.
    PubMed    


    February 2019
  45. YANDRAPALLI S, Nabors C, Goyal A, Aronow WS, et al
    Modifiable Risk Factors in Young Adults With First Myocardial Infarction.
    J Am Coll Cardiol. 2019;73:573-584.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Dyslipidemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: